BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/21/2026 5:59:39 AM | Browse: 5 | Download: 0
Publication Name World Journal of Nephrology
Manuscript ID 120295
Country United Kingdom
Category Endocrinology & Metabolism
Manuscript Type Opinion Review
Article Title Efficacy of finerenone in reducing proteinuria in diabetic kidney disease on dapagliflozin and telmisartan: A disease-modifying approach
Manuscript Source Invited Manuscript
All Author List Antresa Jose, Abul Bashar Mohammad Kamrul-Hasan, Cornelius J Fernandez and Joseph M Pappachan
Funding Agency and Grant Number
Corresponding Author Joseph M Pappachan, FRCP, MD, MRCP, Professor, Senior Researcher, Faculty of Science,, Manchester Metropolitan University, Manchester, Manchester M15 6BH, Greater Manchester, United Kingdom. drpappachan@yahoo.co.in
Key Words Diabetic kidney disease; Chronic kidney disease; Disease-modifying treatment; Mineralocorticoid receptor antagonists; Renin-angiotensin-aldosterone system
Core Tip Diabetic kidney disease (DKD) is a leading cause of morbidity and mortality in people with diabetes mellitus. Traditional disease-modifying treatments do not fully target the underlying mechanisms. The renin-angiotensin-aldosterone system is over activated and only partially suppressed by the renin-angiotensin-aldosterone system blockers like angiotensin- converting enzyme inhibitors or angiotensin II receptor blockers in the context of diabetic kidney disease (DKD). This article is based on the latest research evidence and discusses the relevant strategies for treating diabetic nephropathy patients.
Citation Jose A, Kamrul-Hasan ABM, Fernandez CJ, Pappachan JM. Efficacy of finerenone in reducing proteinuria in diabetic kidney disease on dapagliflozin and telmisartan: A disease-modifying approach. World J Nephrol 2026; In press
Received
2026-02-24 06:05
Peer-Review Started
2026-02-24 06:05
First Decision by Editorial Office Director
2026-02-28 06:59
Return for Revision
2026-02-28 06:59
Revised
2026-03-05 09:30
Publication Fee Transferred
Second Decision by Editor
2026-04-21 02:51
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-04-21 05:59
Articles in Press
2026-04-21 05:59
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-6124 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com